LUCAS ROGER C 4
4 · ChemoCentryx, Inc. · Filed Aug 3, 2017
Insider Transaction Report
Form 4
LUCAS ROGER C
Director
Transactions
- Sale
Common Stock
2017-08-01$10.07/sh−2,250$22,667→ 93,846 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.95 to $10.17 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.